Skip to main content

Advertisement

SpringerLink
Log in

Systematically Optimized Ketoprofen-Loaded Novel Proniosomal Formulation for Periodontitis: In Vitro Characterization and In Vivo Pharmacodynamic Evaluation

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

ABSTRACT

Various preclinical/clinical studies support the effectiveness of ketoprofen in periodontitis; however, the literature reveals that novel delivery systems have been less explored for the drug in periodontitis. The current investigation aims to explore the potential of a pro-vesicular approach-based proniosomal drug delivery of ketoprofen for its effectiveness and validation in experimental periodontal disease (EPD). Formulations were developed using I-optimal mixture design. Developed formulations were characterized for entrapment efficiency, vesicle size, and in vitro drug release. Selected proniosomal gels were evaluated for mucoadhesiveness, ex vivo drug permeation, and retention studies. Optimized proniosomal gel was evaluated for surface morphology, rheological behavior, texture studies, and pharmacodynamic activity in EPD. The results showed that ketoprofen-loaded proniosomal formulations formed a mucoadhesive hydrogel comprising spherical and flexible vesicles. Viscosity and texture studies showed good adhesion and smoothness, which are desired for enhanced permeation. The disease condition was improved with preserved bone resorption process, that too with intact cementum vis-à-vis marketed gel formulation, when evaluated in the EPD model. The results lead to the conclusion that proniosomes can act as a promising carrier and can be effectively used for improved ketoprofen delivery in periodontal pockets.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14
Fig. 15

Similar content being viewed by others

References

  1. Chambrone LA, Chambrone L. Tooth loss in well-maintained patients with chronic periodontitis during long-term supportive therapy in Brazil. J Clin Periodontol. 2006;33:759–64.

    Article  PubMed  Google Scholar 

  2. Howell TH, Williams RC. Nonsteroidal antiinflammatory drugs as inhibitors of periodontal disease progression. Crit Rev Oral Biol Med. 1993;4:177–96.

    Article  CAS  PubMed  Google Scholar 

  3. Page RC. The role of inflammatory mediators in the pathogenesis of periodontal disease. Periodontal Res. 1991;26:230–42.

    Article  CAS  Google Scholar 

  4. Srinivas M, Medaiah S, Girish S, Anil M, Pai J, Walvekar A. The effect of ketoprofen in chronic periodontitis: a clinical double-blind study. J Indian Soc Periodontol. 2011;15:255–9. doi:10.4103/0972-124X.85670.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Funosas E, Feser G, Escovich L, Maestri L. Alteration of hemostasis in patients treated with subgingival NSAIDs during periodontal therapy. Acta Odontol Latnoam. 2012;25:103–8.

    Google Scholar 

  6. Offenbacher S, Odle BM, Green MD, Mayambala CS, Smith MA, Fritz ME, et al. Inhibition of human periodontal prostaglandin E2 synthesis with selected agents. Agents Actions. 1990;29:232–8.

  7. Paquette DW, Lawrence HP, McCombs GB, Wilder R, Binder TA, Troullos E, et al. Pharmacodynamic effects of ketoprofen on crevicular fluid prostanoids in adult periodontitis. J Clin Periodontol. 2000;27:558–66.

    Article  CAS  PubMed  Google Scholar 

  8. Li KL, Vogel R, Jeffcoat MK, Alfano EM, Smith MA, Collins JG, et al. The effect of ketoprofen creams on periodontal disease in rhesus monkeys. J Periodontal Res. 1996;31:525–32.

    Article  PubMed  Google Scholar 

  9. Srivastava M, Kohli K, Ali M. Formulation development of novel in situ nanoemulgel (NEG) of ketoprofen for the treatment of periodontitis. Drug Deliv. 2016;23:154–66. doi:10.3109/10717544.2014.907842.

    Article  CAS  PubMed  Google Scholar 

  10. Sundararaj SC, Thomas MV, Peyyala R, Dziubla TD, Puleo DA. Design of a multiple drug delivery system directed at periodontitis. Biomaterials. 2013;34:8835–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Fang JY, Yu SY, Wu PC, Huang YB, Tsai YH. In vitro skin permeation of estradiol from various proniosome formulations. Int J Pharm. 2001;215:91–9.

    Article  CAS  PubMed  Google Scholar 

  12. Alsarra IA, Bosela AA, Ahmed SM, Mahrous GM. Proniosomes as a drug carrier for transdermal delivery of ketorolac. Eur J Pharm Biopharm. 2005;59:485–90.

    Article  CAS  PubMed  Google Scholar 

  13. El-Laithy HM, Shoukry O, Mahran LG. Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies. Eur J Pharm Sci. 2011;77:43–55.

    CAS  Google Scholar 

  14. Ammar HO, Ghorab M, El-Nahhas SA, Higazy IM. Proniosomes as a carrier system for transdermal delivery of tenoxicam. Int J Pharm. 2011;405:142–52.

    Article  CAS  PubMed  Google Scholar 

  15. Singh B, Kapil R, Nandi M, Ahuja N. Developing oral drug delivery system using formulation by design: vital precepts, retrospect and prospects. Expert Opin Drug Deliv. 2011;8:1341–60.

    Article  CAS  PubMed  Google Scholar 

  16. Yadav NK, Raghuvanshi A, Sharma G, Beg S, Katare OP, Nanda S. QbD-based development and validation of a stability-indicating HPLC method for estimating ketoprofen in bulk drug and proniosomal vesicular system. J Chromatogr Sci. 2016;54(3):377–89. doi:10.1093/chromsci/bmv151.

    CAS  PubMed  Google Scholar 

  17. Tiwari S, Mishra B. Multilayered membrane-controlled microcapsules for controlled delivery of isoniazid. Daru. 2011;19:41–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Ansari M, Kazemipour M, Aklamli M. The study of drug permeation through natural membranes. Int J Pharm. 2006;327:6–11.

    Article  CAS  PubMed  Google Scholar 

  19. Krishnamoorthy V, Prasad VPR. Physicochemical characterization and in vitro dissolution behavior of olanzapine-mannitol solid dispersions. Braz J Pharm Sci. 2012;48:243–55.

    Article  CAS  Google Scholar 

  20. Vora B, Khopade AJ, Jain NK. Proniosome based transdermal delivery of levonorgestrel for effective contraception. J Control Release. 1998;54:149–65.

    Article  CAS  PubMed  Google Scholar 

  21. Rowe RC, Sheskey PJ, Quinn ME. Handbook of pharmaceutical excipients. 6th ed. London: Pharmaceutical Press; 2009.

    Google Scholar 

  22. Bansal K, Rawat MK, Jain A, Rajput A, Chaturvedi TP, Singh S. Development of satranidazole mucoadhesive gel for the treatment of periodontitis. AAPS PharmSciTech. 2009;10:716–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Mashru R, Sutariya V, Sankalia M, Sankalia J. Transbuccal delivery of lamotrigine across porcine buccal mucosa: in vitro determination of routes of buccal transport. J Pharm Pharm Sci. 2005;8:54–62.

    CAS  PubMed  Google Scholar 

  24. Mahalingam R, Ravivarapu H, Redkar S, Li X, Jasti BR. Transbuccal delivery of 5-aza-2′-deoxycytidine: effects of drug concentration, buffer solution, and bile salts on permeation. AAPS PharmSciTech. 2007;8:E28–33.

    Article  PubMed Central  Google Scholar 

  25. Raza K, Singh B, Lohan S, Sharma G, Negi P, Yachha Y, et al. Nano-lipoidal carriers of tretinoin with enhanced percutaneous absorption, photostability, biocompatibility and anti-psoriatic activity. Int J Pharm. 2013;456:65–72.

    Article  CAS  PubMed  Google Scholar 

  26. Basu S, Shivhare US, Raghavan GSV. Time dependent rheological characteristics of pineapple jam. Int J Food Eng. 2007;3:3. doi:10.2202/1556-3758.1229.

  27. Raza K, Shareef MA, Singal P, Sharma G, Negi P, Katare OP. Lipid-based capsaicin-loaded nano-colloidal biocompatible topical carriers with enhanced analgesic potential and decreased dermal irritation. J Liposome Res. 2014;24:290–6.

    Article  CAS  PubMed  Google Scholar 

  28. Negi P, Singh B, Sharma G, Beg S, Raza K, Katare OP. Phospholipid microemulsion-based hydrogel for enhanced topical delivery of lidocaine and prilocaine: QbD-based development and evaluation. Drug Deliv. 2016;23:951–67. doi:10.3109/10717544.2014.923067.

    PubMed  Google Scholar 

  29. Botelho MA, Martins JG, Ruela RS, Queiroz DB, Ruela WS. Nanotechnology in ligature-induced periodontitis: protective effect of a doxycycline gel with nanoparticules. J Appl Oral Sci. 2010;18:335–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Leite CL, Redins CA, Vasquez EC, Meyrelles SS. Experimental-induced periodontitis is exacerbated in spontaneously hypertensive rats. Clin Exp Hypertens. 2005;27:523–31.

    Article  PubMed  Google Scholar 

  31. Xu Y, Wei W. A comparative study of systemic subantimicrobial and topical treatment of minocycline in experimental periodontitis of rats. Arch Oral Biol. 2006;51:794–803.

    Article  CAS  PubMed  Google Scholar 

  32. Ibrahim MMA, Sammour OA, Hammad MA, Megrab NA. In vitro evaluation of proniosomes as a drug carrier for flurbiprofen. AAPS PharmSciTech. 2008;9:782–90. doi:10.1208/s12249-008-9114-0.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Djuris J, Vasiljevic D, Jokic S, Ibric S. Application of D‐optimal experimental design method to optimize the formulation of o/w cosmetic emulsions. Int J Cosmet Sci. 2014;36:79–87.

    Article  CAS  PubMed  Google Scholar 

  34. Jin X, Zhang Y, Xiao L, Zhao Z. Optimization of extended zero-order release gliclazide tablets using D-optimal mixture design. Yakugaku Zasshi. 2008;128:1475–83.

    Article  CAS  PubMed  Google Scholar 

  35. Mokhtar M, Sammour OA, Hammad MA, Megrab NA. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm. 2008;361:104–11.

    Article  CAS  PubMed  Google Scholar 

  36. Patel D, Dasgupta S, Dey S, Roja Ramani Y, Ray S, Mazumder B. Nanostructured lipid carriers (NLC)-based gel for the topical delivery of aceclofenac: preparation, characterization, and in vivo evaluation. Sci Pharm. 2012;80:749–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Pathan IB, Setty CM. Chemical penetration enhancers for transdermal drug delivery systems. J Pharm Res. 2009;8:173–9.

    CAS  Google Scholar 

  38. Hathout RM, Mansour S, Mortada ND, Guinedi AS. Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies. AAPS PharmSciTech. 2007;8:E1–12.

    Article  PubMed Central  Google Scholar 

  39. Bhatia A, Singh B, Raza K, Wadhwa S, Katare OP. Tamoxifen-loaded lecithin organogel (LO) for topical application: development, optimization and characterization. Int J Pharm. 2013;444:47–59.

    Article  CAS  PubMed  Google Scholar 

  40. Williams RC. Periodontal disease. N Engl J Med. 1990;322:373–82.

    Article  CAS  PubMed  Google Scholar 

  41. Carvalho RS, De Souza CM, Neves JC, Holanda-Pinto SA, Pinto LM, Brito GA, et al. Research effect of venlafaxine on bone loss associated with ligature-induced periodontitis in Wistar rats. J Negat Results Biomed. 2010;9:3. doi:10.1186/1477-5751-9-3.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Wahl SM, Costa GL, Mizel DE, Allen JB, Skaleric U, Mangan DF. Role of transforming growth factor beta in the pathophysiology of chronic inflammation. J Periodontal. 1993;64:450–5.

    CAS  Google Scholar 

Download references

Acknowledgements

The authors are thankful to M/s BEC Chemicals (Mumbai, India), VAV Life Sciences (Mumbai, India), and M/s Lubrizol (Mumbai, India) for generously providing the gift samples of ketoprofen, soya lecithin, and Carbopol® 974P, respectively. The authors are also grateful to M/s Jubilant Life Sciences Ltd. (Noida, India) for providing the research facilities for a part of the research work.

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, 124001, India

    N. K. Yadav & Sanju Nanda

  2. Division of Pharmaceutics, University Institute of Pharmaceutical Sciences, UGC Centre of Advanced Studies, Panjab University, Chandigarh, 160 014, India

    Gajanand Sharma & O. P. Katare

Authors
  1. N. K. Yadav
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sanju Nanda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gajanand Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. O. P. Katare
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Sanju Nanda or O. P. Katare.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yadav, N.K., Nanda, S., Sharma, G. et al. Systematically Optimized Ketoprofen-Loaded Novel Proniosomal Formulation for Periodontitis: In Vitro Characterization and In Vivo Pharmacodynamic Evaluation. AAPS PharmSciTech 18, 1863–1880 (2017). https://doi.org/10.1208/s12249-016-0665-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-016-0665-1

KEY WORDS

Search

Navigation